ATE487734T1 - Polypeptide, abgeleitet von der amyloid vorläuferprotein (app), und ihre verwendungen - Google Patents

Polypeptide, abgeleitet von der amyloid vorläuferprotein (app), und ihre verwendungen

Info

Publication number
ATE487734T1
ATE487734T1 AT02720228T AT02720228T ATE487734T1 AT E487734 T1 ATE487734 T1 AT E487734T1 AT 02720228 T AT02720228 T AT 02720228T AT 02720228 T AT02720228 T AT 02720228T AT E487734 T1 ATE487734 T1 AT E487734T1
Authority
AT
Austria
Prior art keywords
app
precursor protein
amyloid precursor
polypeptides derived
polypeptides
Prior art date
Application number
AT02720228T
Other languages
English (en)
Inventor
Radmila Mileusnic
Steven Peter Russell Rose
Original Assignee
Univ Open
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0109558A external-priority patent/GB0109558D0/en
Priority claimed from US09/998,491 external-priority patent/US7491702B2/en
Priority claimed from GB0207387A external-priority patent/GB0207387D0/en
Application filed by Univ Open filed Critical Univ Open
Priority claimed from PCT/GB2002/001769 external-priority patent/WO2002083729A2/en
Application granted granted Critical
Publication of ATE487734T1 publication Critical patent/ATE487734T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/03Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711Alzheimer's disease; Amyloid plaque core protein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K4/00Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • C07K5/0817Tripeptides with the first amino acid being basic the first amino acid being Arg
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1019Tetrapeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT02720228T 2001-04-18 2002-04-17 Polypeptide, abgeleitet von der amyloid vorläuferprotein (app), und ihre verwendungen ATE487734T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0109558A GB0109558D0 (en) 2001-04-18 2001-04-18 Polypeptides and their uses
GB0120084A GB0120084D0 (en) 2001-04-18 2001-08-17 Polypeptides and their uses
US09/998,491 US7491702B2 (en) 2001-04-18 2001-11-30 Polypeptides related to amyloid precursor protein, pharmaceutical compositions thereof, and methods of treatment using the same
GB0207387A GB0207387D0 (en) 2002-03-28 2002-03-28 Polypeptide derivatives and their uses
PCT/GB2002/001769 WO2002083729A2 (en) 2001-04-18 2002-04-17 Polypeptides derived from amyloid precursor peptide (app) and their uses

Publications (1)

Publication Number Publication Date
ATE487734T1 true ATE487734T1 (de) 2010-11-15

Family

ID=43038231

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02720228T ATE487734T1 (de) 2001-04-18 2002-04-17 Polypeptide, abgeleitet von der amyloid vorläuferprotein (app), und ihre verwendungen

Country Status (6)

Country Link
AT (1) ATE487734T1 (de)
CY (1) CY1111301T1 (de)
DE (1) DE60238243D1 (de)
DK (1) DK1381627T3 (de)
ES (1) ES2355808T3 (de)
PT (1) PT1381627E (de)

Also Published As

Publication number Publication date
PT1381627E (pt) 2011-02-15
DK1381627T3 (da) 2011-02-21
ES2355808T3 (es) 2011-03-31
CY1111301T1 (el) 2015-08-05
DE60238243D1 (de) 2010-12-23

Similar Documents

Publication Publication Date Title
EP1504099A4 (de) Neue nukleinsäuren und polypeptide
EP1432800A4 (de) Neue nukleinsäuren und polypeptide
EP1556490A4 (de) Neue nukleinsäuren und polypeptide
IL161016A (en) Polypeptides capable of ang-2 binding
ATE323723T1 (de) Hasylierte polypeptide, besonders hasyliertes erythropoietin
DK2277997T3 (da) Polypeptider med cellobiohydrolase I-aktivitet og polynukleotider, der koder for samme
ZA200308589B (en) Recombinant fusion proteins and the trimers thereof.
DK1463751T3 (da) Albuminfusionsproteiner.
HUP0500992A3 (en) Tacis and br3 polypeptides and uses thereof
DE50213336D1 (de) Substituierte 2-thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre verwendung
DE10295851T1 (de) Dachfensterbaueinheit und Einzelteile
DE50207849D1 (de) Substituierte 2-oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre verwendung
EP1359937A4 (de) Veränderte peptidliganden
EP1549663A4 (de) Multifunktionelle polypeptide
WO2006066024A3 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
DE02784674T1 (de) Quantifizierung von polypeptiden
ITRM990803A0 (it) Peptidi stabilizzanti, polipeptidi ed anticorpi che li comprendono.
DE60332711D1 (de) Neue insektizide proteine von bazillus thuringiensis
EP1368475A4 (de) Neue nukleinsäuren und polypeptide
EP0973893A4 (de) Intrazelluläre, amyloid-beta-bindende polypeptide (erab).
EP1483386A4 (de) Neue nukleinsäuren und abgesonderte polypeptide
NO20052422D0 (no) Stabiliserte, fast tilstand polypeptidpartikler.
NO20035370D0 (no) Karakterisere polypeptider
EP1359932A4 (de) Tip39 polypeptide
NO20035369D0 (no) Karakterisere polypeptider

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1381627

Country of ref document: EP